Health Price To Sales Ratio from 2010 to 2024
| HCAT Stock | USD 8.65 0.15 1.76% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 1.76535142 | Current Value 1.68 | Quarterly Volatility 5.53096614 |
Check Health Catalyst financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Health Catalyst's main balance sheet or income statement drivers, such as Tax Provision of 373.8 K, Net Interest Income of 9.6 M or Interest Income of 17.2 M, as well as many indicators such as Price To Sales Ratio of 1.68, Dividend Yield of 0.0 or PTB Ratio of 1.0. Health financial statements analysis is a perfect complement when working with Health Catalyst Valuation or Volatility modules.
Health | Price To Sales Ratio |
Latest Health Catalyst's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Health Catalyst over the last few years. Price to Sales Ratio is figured by comparing Health Catalyst stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Health Catalyst sales, a figure that is much harder to manipulate than other Health Catalyst multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Health Catalyst's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Health Catalyst's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.74 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Health Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 10.35 | |
| Geometric Mean | 8.10 | |
| Coefficient Of Variation | 53.41 | |
| Mean Deviation | 4.83 | |
| Median | 14.88 | |
| Standard Deviation | 5.53 | |
| Sample Variance | 30.59 | |
| Range | 13.2024 | |
| R-Value | (0.89) | |
| Mean Square Error | 6.97 | |
| R-Squared | 0.79 | |
| Slope | (1.10) | |
| Total Sum of Squares | 428.28 |
Health Price To Sales Ratio History
About Health Catalyst Financial Statements
Health Catalyst shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Health Catalyst investors may analyze each financial statement separately, they are all interrelated. The changes in Health Catalyst's assets and liabilities, for example, are also reflected in the revenues and expenses on on Health Catalyst's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.77 | 1.68 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.